0001104659-22-001621.txt : 20220105
0001104659-22-001621.hdr.sgml : 20220105
20220105185320
ACCESSION NUMBER: 0001104659-22-001621
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220105
FILED AS OF DATE: 20220105
DATE AS OF CHANGE: 20220105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MACFARLANE M DAVID
CENTRAL INDEX KEY: 0001182314
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13341
FILM NUMBER: 22512981
MAIL ADDRESS:
STREET 1: C/O TITAN PHARMACEUTICALS INC
STREET 2: 400 OYSTER POINT BLVD
CITY: S SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000910267
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943171940
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6502444990
MAIL ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
tm221868-4_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-01-05
0
0000910267
TITAN PHARMACEUTICALS INC
TTNP.OB
0001182314
MACFARLANE M DAVID
400 OYSTER POINT BLVD., SUITE 505
SO. SAN FRANCISCO
CA
94080
1
0
0
0
Option to Purchase Common Stock
1.18
2022-01-05
4
A
0
10000
0
A
2022-07-05
2032-01-05
Common Stock
10000
10000
D
/S/ M. David MacFarlane
2022-01-05